Copyright
©The Author(s) 2005.
World J Gastroenterol. Aug 21, 2005; 11(31): 4865-4868
Published online Aug 21, 2005. doi: 10.3748/wjg.v11.i31.4865
Published online Aug 21, 2005. doi: 10.3748/wjg.v11.i31.4865
Table 1 Baseline characteristics of patients
| Erythromycin (n = 24) | Control (n = 14) | |
| Mean age±SD (yr) | 62.7±17.8 | 56.3±18.6 |
| Male (%) | 9 (37.5) | 8 (57.1) |
| Mean body mass index (±SD) | 22.9±3.8 | 22.3±3.2 |
| Diabetes mellitus (%) | 7 (29.2) | 3 (21.4) |
| Indication | ||
| Iron deficiency anemia (%) | 6 (25) | 5 (36) |
| Obscure gastro-intestinal bleeding (%) | 12 (50) | 8 (57) |
| Recurrent abdominal pain (%) | 5 (21) | 1 (7) |
| Crohn’s disease (%) | 1 (4) | 0 (0) |
- Citation: Leung WK, Chan FK, Fung SS, Wong MY, Sung JJ. Effect of oral erythromycin on gastric and small bowel transit time of capsule endoscopy. World J Gastroenterol 2005; 11(31): 4865-4868
- URL: https://www.wjgnet.com/1007-9327/full/v11/i31/4865.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i31.4865